Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders (QoQ) (2009 - 2026)
Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn |
| 2 | Stryker | 128.56 Bn | 125.08 Bn | 4.50 Bn |
| 3 | Medtronic | 119.26 Bn | 110.04 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn |
| 6 | Dexcom | 34.55 Bn | 32.61 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.31 Bn | 18.90 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.24% |
| Mar 31, 2026 | 129.05% |
| Dec 31, 2025 | -454.84% |
| Sep 30, 2025 | 50.72% |
| Jun 30, 2025 | -15.95% |
| Mar 31, 2025 | 133.50% |
| Dec 31, 2024 | -318.58% |
| Sep 30, 2024 | 2.51% |
| Jun 30, 2024 | 40.68% |
| Mar 31, 2024 | -58.83% |
| Dec 31, 2023 | 157.80% |
| Sep 30, 2023 | -22.44% |
| Jun 30, 2023 | -9.80% |
| Mar 31, 2022 | -101.37% |
| Dec 31, 2021 | -75.90% |
| Sep 30, 2021 | -621.74% |
| Jun 30, 2021 | -148.94% |
| Mar 31, 2021 | -98.83% |
| Dec 31, 2020 | 63.06% |
| Sep 30, 2020 | 218.20% |